Suppression of HBV DNA in patients with HBeAg-negative CHB treated with peginterferon alfa-2A (40KD) +/- lamivudine: 2-year follow-up results


Marcellin P., Bonino F., Lau G. K. , Farci P., Yurdaydin C., Piratvisuth T., ...More

57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 27 - 31 October 2006, vol.44 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 44
  • City: Massachusetts
  • Country: United States Of America